Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-019704
Filing Date
2025-07-14
Accepted
2025-07-14 16:15:25
Documents
2
Period of Report
2025-07-04

Document Format Files

Seq Description Document Type Size
1 form3-07142025_080721.html 3  
1 form3-07142025_080721.xml 3 5306
2 ex24-07142025_080723.htm EX-24 4516
  Complete submission text file 0001415889-25-019704.txt   11432
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Pangali Sanam (Reporting) CIK: 0002023806 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42143 | Film No.: 251121876